1. RAS‐targeted cancer therapy: Advances in drugging specific mutations
   Cen Liu et al, 2023, MedComm CrossRef
2. Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours
   Andrew Rowland et al, 2016, European Journal of Cancer CrossRef
3. Study of KRAS-Related miRNA Expression in Colorectal Cancer
   Xiaobing Wu et al, 2022, Cancer Management and Research CrossRef
4. SFPQ promotes RAS-mutant cancer cell growth by modulating 5′-UTR mediated translational control of CK1α
   Venetia Jing Tong Kok et al, 2022, NAR Cancer CrossRef
5. Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
   Alessia Bignucolo et al, 2017, International Journal of Molecular Sciences CrossRef
6. Complete Response With Cetuximab-Based Treatment of Metastatic Colorectal Cancers: Two Case Reports and Literature Review
   Li Wei et al, 2022, Frontiers in Oncology CrossRef
7. The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care
   Marina De Rosa et al, 2016, Therapeutic Advances in Gastroenterology CrossRef
8. Drug resistance and new therapies in colorectal cancer
   Kevin Van der Jeught et al, 2018, World Journal of Gastroenterology CrossRef
9. Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study
   Eva Segelov et al, 2016, Journal of Clinical Oncology CrossRef
10. Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
    Mimmo Turano et al, 2019, Cancers CrossRef
11. Deregulation of the miR-16-KRAS axis promotes colorectal cancer
    Chaoying You et al, 2016, Scientific Reports CrossRef
12. Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer
    Min Seob Kwak et al, 2017, Medicine CrossRef
13. ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer
    Prajish Iyer et al, 2019, International Journal of Cancer CrossRef